Mahmoudreza Alebouyeh, Saeedreza Entezari, Behrooz Zaman, Poupak Rahimzadeh, Hamidreza Khabaz,
Volume 15, Issue 3 (12-2024)
Abstract
Abstract
Background and Aim: The aim of the present study was to compare the effect of intercostobrachial nerve block versus axillary nerve block on the level of tourniquet pain in patients undergoing upper limb surgery with infraclavicular block.
Material and Method: This study was a randomized, single-blinded clinical trial. After obtaining consent, 30 patients were randomly divided into 2 groups. The first group (15 patients) received 5 cc of 0.5% ropivacaine for intercostobrachial nerve block, and the second group (15 patients) received 5 cc of 0.5% ropivacaine for axillary nerve block subcutaneously. Patients' satisfaction was measured using a questionnaire, and the data were analyzed using SPSS version 26 software.
Results: 30 patients (15 men and 15 women) were included. The mean age was 42.33 ± 13.62 years in the Axillary block group and 48.07 ± 17.71 years in the Intercostobrachial block group. None of the patients in either group reported pain in the tourniquet area and did not require opioid administration. The determination of patient satisfaction level did not show a significant difference between the two groups (P-Value=0.553). The distribution of mean systolic (P-Value=0.789) and diastolic (P-Value=0.942) blood pressure before and after tourniquet application after 4 measurements did not show a significant difference.
Conclusion: The findings indicate that the use of intercostobrachial and axillary nerve blocks results in the elimination of pain in the tourniquet area, and there is no need for systemic opioid medications. Most patients were highly satisfied with the surgical procedure.
